278 material Form 8-K filings that 243 companies we cover made with the SEC in May 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Marcus & Millichap reported first-quarter 2024 total revenue of $129.1 million, down 16.6% from $154.8 million a year earlier, and a net loss of $10.0 million, or $0.26 per diluted share, compared with a net loss of $5.8 million, or $0.15 per share. The company attributed the decline to fewer transactions in a challenging market, and it has not yet filed its Form 10-Q, so the results are preliminary.
Brokerage commissions fell 18.9% to $109.5 million, primarily on a 13.8% decrease in the number of transactions.
Net loss was $10.0 million, or $0.26 per diluted share, versus $5.8 million, or $0.15 per diluted share, in the first quarter of 2023.
Adjusted EBITDA was $(10.1) million, compared with $(7.4) million a year earlier.
At the May 2, 2024 annual meeting, the say-on-pay proposal passed with 25,888,652 votes for and 10,534,106 against.
RingCentral reported first quarter 2024 results on May 7, 2024, with total revenue up 9% year-over-year to $584 million and diluted non-GAAP net income per share of $0.87, compared with $0.76 a year earlier. The company raised its full-year 2024 revenue and non-GAAP EPS guidance and increased its share repurchase authorization by $250 million. The filing also discloses a routine board committee assignment for director Prat Bhatt.
Q1 2024 total revenue was $584 million, up from $534 million; GAAP net loss per share narrowed to $0.31 from $0.57.
2024 total revenue guidance raised to $2.379 billion to $2.399 billion; non-GAAP EPS guidance raised to $3.59 to $3.67.
Board increased the share repurchase authorization by $250 million; about $375 million remains under the total authorization.
Director Prat Bhatt was appointed to the Compensation Committee on May 1, 2024.
Protagonist reported first-quarter 2024 net income of $207.3 million, or $3.41 per basic share, compared with a net loss of $33.7 million a year earlier. The results were driven mainly by $255.0 million of license and collaboration revenue from the Takeda rusfertide agreement, and cash, cash equivalents and marketable securities were $322.6 million at March 31, 2024, down from $341.6 million at December 31, 2023.
Net income of $207.3 million, or $3.41 per basic share, versus a net loss of $33.7 million, or $0.67 per share, in Q1 2023.
License and collaboration revenue of $255.0 million, including $254.1 million allocated to the rusfertide license delivered to Takeda on March 15, 2024.
Cash, cash equivalents and marketable securities of $322.6 million at March 31, 2024, versus $341.6 million at December 31, 2023.
G&A expense of $14.9 million included $4.6 million in advisory and legal fees related to the Takeda collaboration; R&D expense was $33.7 million.
Kyndryl reported fourth-quarter fiscal 2024 revenue of $3.8 billion, down 10% year over year, as it reduced inherited no-margin and low-margin third-party content in customer contracts. The net loss narrowed to $45 million from $737 million a year earlier, and adjusted pretax income rose to $30 million from an adjusted loss of $61 million. For fiscal 2025, the company expects constant-currency revenue growth of (2%) to (4%) and adjusted pretax income of at least $435 million.
Q4 revenue $3.8 billion, down 10% (9% in constant currency); net loss $45 million, or ($0.20) per diluted share, versus $737 million, or ($3.24), a year earlier
Q4 adjusted pretax income $30 million, versus an adjusted pretax loss of $61 million in the prior-year quarter
Fiscal 2024 revenue $16.1 billion, down 6%; net loss $340 million, or ($1.48) per diluted share; adjusted free cash flow $291 million
Fiscal 2025 outlook: revenue growth of (2%) to (4%) in constant currency and adjusted pretax income of at least $435 million, versus $165 million in fiscal 2024
Bio-Rad reported first-quarter 2024 net sales of $610.8 million, down 9.8% from a year earlier, with Life Science sales down 25.3% and Clinical Diagnostics up 4.7%. GAAP net income rose to $383.9 million, or $13.45 per diluted share, mainly due to a $422.2 million gain on equity securities tied to its Sartorius AG holding, while non-GAAP net income fell to $65.2 million, or $2.29 per share, from $3.34 a year earlier.
Net sales $610.8 million vs. $676.8 million in Q1 2023, a 9.8% decline; Life Science down 25.3%, Clinical Diagnostics up 4.7%
Income from operations $44.7 million vs. $61.9 million; non-GAAP operating margin 9.7% vs. 12.4%
GAAP net income $383.9 million ($13.45 per diluted share) vs. $69.0 million ($2.32), driven by changes in the fair market value of Sartorius AG-related equity securities
Full-year 2024 outlook maintained: non-GAAP currency-neutral revenue growth of approximately 1.0% to 2.5% and non-GAAP operating margin of approximately 13.5% to 14.0%
Red Rock Resorts reported first quarter 2024 results, with net revenues up 12.7% to $488.9 million and Adjusted EBITDA up 7.7% to $209.1 million. Net income fell 8.4% to $78.4 million, and diluted earnings per share were $0.68 versus $0.75 a year earlier, so top-line growth did not carry through to bottom-line profit for shareholders.
Net revenues were $488.9 million, up $55.3 million from $433.6 million in Q1 2023
Net income was $78.4 million, down $7.2 million from $85.5 million; diluted EPS was $0.68 versus $0.75
Loss on extinguishment/modification of debt was $14.4 million; interest expense, net was $57.2 million
Board declared a $0.25 per Class A share dividend payable June 28, 2024 to holders of record on June 14, 2024
Reddit reported first-quarter 2024 results, with revenue up 48% year-over-year to $243.0 million and a net loss of $575.1 million, compared with $60.9 million a year earlier. The company said the loss was driven by stock-based compensation and related taxes of $595.5 million tied to IPO charges, while Adjusted EBITDA swung to a profit of $10.0 million. The filing also added Sarah Farrell to the board and gave second-quarter revenue and Adjusted EBITDA ranges.
Q1 2024 revenue was $243.0 million, up 48% year-over-year; advertising revenue was $222.7 million, up 39%
Net loss was $575.1 million versus $60.9 million in Q1 2023, driven by $595.5 million of stock-based compensation and related taxes tied to IPO charges
Adjusted EBITDA was $10.0 million versus a loss of $(50.2) million a year earlier; operating cash flow was $32.1 million
Q2 2024 estimates: revenue of $240 million to $255 million and Adjusted EBITDA of $0 to $15 million; Sarah Farrell joined the board May 2, 2024
Veeco reported first quarter 2024 revenue of $174.5 million, up from $153.5 million a year earlier, and GAAP net income of $21.9 million, or $0.37 per diluted share, versus $8.7 million, or $0.17, in the prior-year quarter. The company guided second quarter 2024 revenue to $165 million to $185 million and non-GAAP diluted EPS to $0.38 to $0.48.
Q1 2024 revenue $174.5 million vs. $153.5 million in Q1 2023
Q1 2024 GAAP diluted EPS $0.37 vs. $0.17; non-GAAP diluted EPS $0.45 vs. $0.30
Q2 2024 guidance: revenue $165 million to $185 million; GAAP diluted EPS $0.22 to $0.33
Q1 2024 cash flow from operations was $9 million vs. $29 million in Q4 2023
Twilio reported first quarter 2024 revenue of $1.05 billion, up 4% year over year, and a GAAP loss from operations of $44 million, compared with a $264 million loss a year earlier. The company raised its full-year 2024 non-GAAP income from operations guidance to $585 million to $635 million and initiated second quarter guidance for revenue of $1,050 million to $1,060 million, which the filing says is 1% to 2% growth.
Q1 2024 non-GAAP income from operations was $160 million, versus $104 million in Q1 2023; GAAP net loss narrowed to $55 million ($0.31 per share) from $342 million ($1.84 per share).
Full-year 2024 non-GAAP income from operations guidance raised to $585 million to $635 million; organic revenue growth guidance of 5% to 10% was reaffirmed.
Q2 2024 guidance: revenue of $1,050 million to $1,060 million and non-GAAP income from operations of $135 million to $145 million.
Board authorized an additional $2.0 billion of share repurchases in March 2024; the company says about $1.5 billion has been completed and it targets the remaining $1.5 billion before the end of 2024.
Penumbra reported first-quarter 2024 revenue of $278.7 million, up 15.4% from a year earlier, and GAAP net income of $11.0 million, or $0.28 per diluted share, compared with $8.6 million, or $0.22, in the first quarter of 2023. The company reiterated its full-year 2024 revenue guidance of $1,230.0 million to $1,270.0 million, which reflects 16% to 20% growth.
Revenue of $278.7 million, up 15.4% from $241.4 million; U.S. revenue rose 22.0% while international revenue fell 0.7%.
GAAP net income of $11.0 million, or $0.28 per diluted share, versus $8.6 million, or $0.22, a year earlier.
Operating expenses included $4.8 million in non-recurring litigation-related expenses in the first quarter of 2024.
Full-year 2024 total revenue guidance of $1,230.0 million to $1,270.0 million was reiterated, and U.S. thrombectomy growth guidance of 27% to 30% was also kept.
Effective May 6, 2024, Laureate Education agreed to buy 2,114,928 common shares from six Snow Phipps Group entities at $14.64 per share, a total of $30,958,422. The shares will be repurchased under the company's existing $100 million share repurchase program, announced February 22, 2024. The filing states that about $36.1 million of authorization will remain after the purchase, so the deal uses a portion of the program's capacity.
Purchase price of $14.64 per share, for an aggregate $30,958,422 across 2,114,928 shares
Shares are repurchased under the $100 million program announced February 22, 2024
About $36.1 million of authorization remains under the program after this purchase
Agreement effective May 6, 2024; filed with the SEC on May 7, 2024
Douglas Emmett reported first quarter 2024 results, with revenue down 2.9% to $245.0 million and net income attributable to common stockholders down 51.5% to $8.9 million, or $0.05 per diluted share. The company left its full-year 2024 FFO per share guidance of $1.64 to $1.70 unchanged, citing expected higher interest expense, so shareholders face lower first quarter earnings with no change to the outlook.
Revenue fell 2.9% to $245.0 million, as lower office occupancy and the removal of Barrington Plaza apartments offset higher residential and parking revenue.
FFO fell 8.7% to $90.1 million, or $0.45 per fully diluted share, mainly due to higher interest expense and lower revenues.
2024 guidance: net income per diluted share of $0.04 to $0.10 and FFO per fully diluted share of $1.64 to $1.70, both unchanged.
Quarterly dividend of $0.19 per common share was paid on April 16, 2024.
ICU Medical reported first quarter 2024 revenue of $566.7 million, down slightly from $568.6 million a year earlier, and a GAAP net loss of $39.5 million, or $1.63 per diluted share, versus a $9.8 million loss, or $0.41 per share, in the first quarter of 2023. Adjusted diluted earnings per share fell to $0.96 from $1.74, and adjusted EBITDA fell to $78.8 million from $102.0 million, so headline profit measures declined for shareholders.
Q1 2024 revenue was $566.7 million versus $568.6 million in Q1 2023.
GAAP net loss was $39.5 million, or $1.63 per diluted share, versus a $9.8 million loss, or $0.41 per share, a year earlier.
Adjusted diluted EPS was $0.96 versus $1.74; adjusted EBITDA was $78.8 million versus $102.0 million.
The filing includes a fiscal year 2024 outlook showing a GAAP net loss of $127 million to $110 million and adjusted diluted EPS of $4.40 to $5.10.
Qualys reported first-quarter 2024 revenue of $145.8 million, up 12% from a year earlier, and GAAP diluted EPS of $1.05 versus $0.77. The company raised its full-year 2024 GAAP EPS guidance to $3.26 to $3.50 and non-GAAP EPS guidance to $5.06 to $5.30, while narrowing its full-year revenue guidance to $601.5 million to $608.5 million. For shareholders, the filing points to higher profit and a higher earnings outlook for 2024.
Q1 2024 revenue of $145.8 million, up 12% from $130.7 million in Q1 2023
GAAP net income of $39.7 million, or $1.05 per diluted share, versus $0.77 a year earlier
Full-year 2024 GAAP EPS guidance raised to $3.26 to $3.50 from $3.11 to $3.43
Second-quarter 2024 revenue guidance of $147.5 million to $149.5 million
Cirrus Logic reported fiscal fourth-quarter 2024 revenue of $371.8 million, above the top end of its guidance range, and GAAP earnings per share of $0.81 compared with a loss of $0.97 a year earlier. Revenue fell 40 percent from the prior quarter, and the company guided June quarter revenue to $290 million to $350 million, which is down 14 percent sequentially at the midpoint.
Q4 FY24 revenue of $371.8 million, down 40 percent quarter over quarter and approximately flat year over year
Q4 GAAP diluted EPS of $0.81 versus a loss of $0.97 a year earlier; non-GAAP EPS of $1.24 versus $0.92
FY24 revenue of $1.79 billion, down six percent; GAAP EPS of $4.90 versus $3.09
Q1 FY25 guidance: revenue of $290 million to $350 million and GAAP gross margin of 49 to 51 percent
Berkshire Hathaway reported first-quarter 2024 net earnings attributable to shareholders of $12.7 billion, down from $35.5 billion a year earlier, mainly because of investment swings. Operating earnings, which exclude investment gains and losses, rose to $11.2 billion from $8.1 billion. Shareholders also met on May 4, 2024, and rejected all six shareholder proposals.
Q1 2024 net earnings: $12.7 billion, versus $35.5 billion in Q1 2023
Q1 2024 operating earnings: $11.2 billion, versus $8.1 billion in Q1 2023
Investment losses included about $9.7 billion of unrealized losses on equity holdings in Q1 2024
All six shareholder proposals were voted down at the May 4, 2024 annual meeting
ScanSource reported third-quarter fiscal 2024 net sales of $752.6 million, down 15.0% year over year, and GAAP diluted EPS of $0.50, down from $0.83. The company lowered its full-year fiscal 2024 guidance for net sales, adjusted EBITDA and free cash flow was raised, and it announced a new $100 million share repurchase authorization.
Q3 net sales $752.6 million, down 15.0%; GAAP net income $12.8 million, down 39.7%
FY24 net sales outlook cut to at least $3.3 billion from at least $3.5 billion; adjusted EBITDA cut to at least $140 million from at least $155 million
FY24 free cash flow outlook raised to at least $275 million from at least $200 million
New $100 million share repurchase authorization; about $45 million remained under the prior authorization as of March 31, 2024
Equifax appointed Barbara A. Larson, former Workday CFO, as an independent director effective May 1, 2024, expanding the board to ten members, nine of them independent. At its May 2, 2024 annual meeting, shareholders elected all nine director nominees and approved executive pay and the appointment of Ernst & Young LLP on an advisory basis, and the filing reports no financial results or guidance changes.
Barbara A. Larson appointed independent director on May 1, 2024; term runs to the 2025 annual meeting; she will serve on the Audit Committee
Mark W. Begor received 109,022,573 votes for; Mark L. Feidler received 99,478,693 votes for, with 7,525,328 against
Shareholders approved named executive officer compensation with 99,361,137 votes for and 10,166,264 against
Shareholders ratified Ernst & Young LLP as auditor for fiscal 2024 with 109,773,935 votes for and 4,301,402 against
Enpro reported first quarter 2024 results on May 7, 2024. Sales fell 8.9% to $257.5 million, GAAP income from continuing operations fell to $12.5 million from $26.0 million, and adjusted diluted EPS fell 19.5% to $1.57, driven mainly by weakness in the Advanced Surface Technologies segment. The company kept its full-year 2024 guidance unchanged, which shareholders may weigh against the weaker quarter.
Sales of $257.5 million, down 8.9%; organic sales down 11.6%
GAAP diluted EPS from continuing operations of $0.59 versus $1.24 a year earlier
Adjusted EBITDA of $58.4 million, down 14.9%; Advanced Surface Technologies sales down 21.4%
Full-year 2024 guidance maintained: adjusted EBITDA of $260-$280 million and adjusted diluted EPS of $7.00 to $7.80
Energizer reported fiscal second-quarter 2024 results for the period ended March 31, 2024. Net sales fell 3.0% to $663.3 million, while GAAP diluted EPS dropped to $0.45 from $0.55 and adjusted diluted EPS rose to $0.72 from $0.64. The company reaffirmed its fiscal 2024 outlook for adjusted EPS of $3.10 to $3.30 and adjusted EBITDA of $600 million to $620 million.
Net sales were $663.3 million versus $684.1 million a year earlier; organic net sales declined 2.7%.
GAAP net earnings were $32.4 million versus $40.0 million, after restructuring charges of $23.4 million versus $7.5 million.
Adjusted diluted EPS was $0.72 versus $0.64; adjusted EBITDA was $142.5 million versus $139.5 million.
Fiscal 2024 outlook for adjusted EPS ($3.10 to $3.30) and adjusted EBITDA ($600 million to $620 million) was reaffirmed.
Crocs, Inc. appointed Susan Healy as Executive Vice President and Chief Financial Officer, effective June 3, 2024, reporting to CEO Andrew Rees. Anne Mehlman, the current CFO, moved to Executive Vice President and Crocs Brand President on May 3, 2024, and will remain CFO until Healy starts. The filing does not report any financial results, guidance, or changes to the company's outlook.
Susan Healy, 58, previously served as CFO of IAA, Inc. from September 2021 until March 2023.
Healy's offer letter sets an annual base salary of $750,000, a 100% target annual bonus, and a $2,000,000 equity grant.
Healy's Change in Control Plan severance payment percentage is 200%; relocation benefits are up to $200,000 (gross).
The company reports fiscal first quarter results the same day, Tuesday, May 7, 2024, before the market opens.
Bentley Systems reported first-quarter 2024 revenue of $337.8 million, up 7.4% from a year earlier, with net income rising to $70.3 million from $45.5 million. The CFO said the strong start puts the company in a good position to achieve its full-year outlook, and the filing reiterates that COO Nicholas Cumins will succeed Greg Bentley as CEO on July 1.
Diluted EPS was $0.22 versus $0.14 a year earlier; adjusted EPS was $0.31 versus $0.25.
Operating income margin was 27.2% versus 20.9%, and cash flow from operations was $205.0 million versus $176.2 million.
Annualized recurring revenues reached $1,186.5 million, up 11% on a constant currency basis.
Last twelve-month dollar-based net retention rate was 108%, down from 110% a year earlier.
Dorman Products reported first quarter 2024 results for the period ended March 30, 2024, with net sales of $468.7 million, up 0.4% from $466.7 million a year earlier. Diluted EPS rose to $1.05 from $0.18, and adjusted diluted EPS rose to $1.31 from $0.56. The company confirmed its full-year 2024 guidance, including diluted EPS of $4.71 to $5.01 and adjusted diluted EPS of $5.40 to $5.70.
Net sales were $468.7 million, up 0.4% from $466.7 million; Light Duty sales rose 3% while Heavy Duty fell 15%
Diluted EPS was $1.05 versus $0.18; adjusted diluted EPS was $1.31 versus $0.56
Operating cash flow was $52 million; the company repaid $15 million of debt and repurchased $27 million of shares
Full-year 2024 guidance was confirmed, with net sales growth of 3% to 5% and adjusted diluted EPS of $5.40 to $5.70
Datadog reported first-quarter 2024 revenue of $611 million, up 27% year-over-year, and GAAP net income of $42.6 million compared with a loss a year earlier. The company also said President Amit Agarwal will step down effective December 31, 2024, and is expected to join the Board afterward, which is a senior leadership change for shareholders to track.
Q1 2024 revenue was $611 million, up 27% year-over-year; about 3,340 customers had ARR of $100,000 or more, up 15% from about 2,910 a year earlier.
GAAP net income was $42.6 million, or $0.12 per diluted share, versus a net loss of $24.1 million in Q1 2023; non-GAAP net income per diluted share was $0.44.
Second quarter 2024 revenue guidance is $620 million to $624 million; full year 2024 revenue guidance is $2.59 billion to $2.61 billion.
Amit Agarwal will remain President until December 31, 2024, and the Board intends to increase its size from eight to nine to appoint him.
Urban Edge Properties reported first-quarter 2024 net income attributable to common shareholders of $2.6 million, or $0.02 per diluted share, compared with a net loss of $19.1 million a year earlier. FFO as Adjusted was $0.33 per diluted share, up from $0.32, and the company raised its full-year 2024 FFO as Adjusted guidance by $0.03 per share at the midpoint to $1.27 to $1.32 per diluted share. For shareholders, the higher guidance points to improved expected core operating earnings for 2024.
Q1 2024 net income attributable to common shareholders was $2.6 million, or $0.02 per diluted share, versus a net loss of $19.1 million in Q1 2023.
Q1 2024 FFO as Adjusted was $0.33 per diluted share, up from $0.32 in Q1 2023; same-property NOI growth was 2.2%.
2024 FFO as Adjusted guidance was raised to $1.27 to $1.32 per diluted share from $1.24 to $1.29.
The company acquired Ledgewood Commons for $83 million on April 5, 2024, and Heritage Square for $34 million on February 8, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.